BioCentury
ARTICLE | Company News

Abcodia, AIT Austrian Institute of Technology deal

June 17, 2013 7:00 AM UTC

Abcodia partnered with the institute to design a series of longitudinal studies to validate panels of biomarkers for the early detection of lung and colorectal cancers. Abcodia will provide its samples free of charge, and AIT will test the samples free of charge. Abcodia said if the biomarkers perform well the company will license them and the partners will jointly commercialize the product and share downstream revenues. The partners hope to generate a data package that will allow the licensing of the IP to a commercial partner. ...